Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 919301-53-4 | MDL No. : | MFCD29477692 |
Formula : | C22H15ClN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | AJSOWJLBAVMDJX-UHFFFAOYSA-N |
M.W : | 342.82 g/mol | Pubchem ID : | 71425220 |
Synonyms : |
|
Num. heavy atoms : | 25 |
Num. arom. heavy atoms : | 24 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 103.35 |
TPSA : | 25.78 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -4.26 cm/s |
Log Po/w (iLOGP) : | 3.83 |
Log Po/w (XLOGP3) : | 5.82 |
Log Po/w (WLOGP) : | 6.13 |
Log Po/w (MLOGP) : | 4.62 |
Log Po/w (SILICOS-IT) : | 6.15 |
Consensus Log Po/w : | 5.31 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 1.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -6.14 |
Solubility : | 0.000246 mg/ml ; 0.000000717 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -6.13 |
Solubility : | 0.000253 mg/ml ; 0.000000738 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -9.78 |
Solubility : | 0.0000000564 mg/ml ; 0.0000000002 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.53 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | Stage #1: 4-chlorobenzaldehyde; acetophenone at 25℃; for 2.5h; Stage #2: benzonitrile With hydroxylamine at 25℃; for 2.5h; Stage #3: at 150℃; for 0.05h; microwave irradiation; Further stages.; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With cholin hydroxide In cyclohexanol at 60℃; for 0.416667h; Green chemistry; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With oxygen; triethylamine In acetonitrile at 80℃; for 5h; | General Procedure for the Synthesis of PyrimidineDerivatives General procedure: A round bottom flask was charged with the substitutedchalcone 1 (1.0 mmol), benzamidine 2 (1.0 mmol), triethylamine(2.0 mmol) and acetonitrile (10 mL). The mixturewas heated to 80 °C for 4-14 h, and then cooled to r.t.Evaporation of the solvent gave a crude reaction mixture, towhich water (10 mL) was added and the resulting mixturewas extracted with EtOAc (3 20 mL). The combined organiclayer was washed with 1N HCl (20 mL), brine anddried over anhydrous Na2SO4. The solvent was concentratedunder reduced pressure and residue obtained was purified bysilica gel column chromatography (100-200 mesh) using nhexane:Et2O (95:05) as the eluent to afford the correspondingpyrimidine 3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With [(4-(4-CF3)-Ph)Tr(NP(iPr)2)(NHP(iPr)2)Ir(cod)]; potassium hydroxide In tert-Amyl alcohol for 24h; Inert atmosphere; Reflux; regioselective reaction; | |
82% | With platinum on activated charcoal; potassium <i>tert</i>-butylate In toluene for 24h; Reflux; | |
75% | With potassium <i>tert</i>-butylate; C22H14N2O In toluene at 70℃; for 8h; Irradiation; Green chemistry; |
[ 58536-46-2 ]
4-(4-Bromophenyl)-2,6-diphenylpyrimidine
Similarity: 0.79
[ 864377-28-6 ]
4-(3-Bromophenyl)-2,6-diphenylpyrimidine
Similarity: 0.78
[ 607740-08-9 ]
4-(3,5-Dibromophenyl)-2,6-diphenylpyrimidine
Similarity: 0.77
[ 1443049-86-2 ]
2-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.76
[ 1443049-83-9 ]
2-(3'-Chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.75
[ 1443049-86-2 ]
2-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.76
[ 1443049-84-0 ]
2-(3'-Chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.75
[ 1443049-83-9 ]
2-(3'-Chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.75
[ 58536-46-2 ]
4-(4-Bromophenyl)-2,6-diphenylpyrimidine
Similarity: 0.79
[ 864377-28-6 ]
4-(3-Bromophenyl)-2,6-diphenylpyrimidine
Similarity: 0.78
[ 607740-08-9 ]
4-(3,5-Dibromophenyl)-2,6-diphenylpyrimidine
Similarity: 0.77
[ 2915-16-4 ]
2-Chloro-4,6-diphenylpyrimidine
Similarity: 0.74
[ 29509-92-0 ]
4-Chloro-6-methyl-2-phenylpyrimidine
Similarity: 0.74